Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Jun 10, 2021)
Date Submitted: Jan 13, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
An App-Based Cognitive Behavioral Therapy Program for Cancer Patients with Sleep Problems: A Pilot Randomized Controlled Trial
ABSTRACT
Objective:
To develop and evaluate an app-based cognitive behavioral therapy program for cancer patients with sleep problems. Method: Sixty participants who met the inclusion criteria were randomly assigned to the app-based cognitive behavioral therapy program (HARUToday Sleep) (N = 15), an app-based attentional control program (HARUCard Sleep) (N = 15), or a waitlist control group (N = 15). HARUToday Sleep consists of 48 sessions separated into five zones (psycho-education, behavioral activation, relaxation training, cognitive restructuring, and problem solving). Each participant was required to complete one 10- to 15-minute session per day on weekdays for 10 weeks. In the HARUCard Sleep, participants received one card per day, which provided information about cancer, hobbies, and activities. Participants were evaluated before and after the completion of the program using self-report questionnaires and a dot-probe computer task that measured attentional bias.
Results:
The intensity of sleep problems decreased significantly after the intervention for the HARUToday Sleep group compared to the other two groups, whereas there were no significant changes in the quality of life score and the attentional bias scores of the patients. Conclusion: The HARUToday Sleep app may be an effective intervention for reducing sleep problems in cancer patients.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.